InMed Pharmaceuticals Inc. (NASDAQ: INM) announced the outcomes of its annual general and special meeting held on December 17, 2025.
Shareholders voted on various matters including the election of the board of directors and the approval of auditors.
InMed confirmed the approval for the potential issuance of common shares pursuant to the Standby Equity Purchase Agreement.
Voting Results
Detailed voting results for the election of the board of directors were provided, showcasing the support for each nominee.
Auditors Approval
CBIZ CPAs P.C. was approved as the Company's auditors for the following year by the shareholders.
Share Issuance Approval
Shareholders also approved the potential issuance of common shares as per the Standby Equity Purchase Agreement.
- The announcement of the voting results and approvals reflects the confidence of shareholders in InMed's leadership and strategic decisions.
- Approval of the share issuance plans indicates potential future growth and funding opportunities for the Company.
The positive outcomes of the meeting demonstrate strong shareholder support for InMed's direction and strategic initiatives, paving the way for future developments in the pharmaceutical industry.